Species-related pharmacological heterogeneity of histamine H3 receptors

European Journal of Pharmacology

Volumn 433, Issue 2-3, 2001, Pages 141-150

  Ireland Denny, Lynne ^a   Parihar, Ashutosh S ^a   Miller, Thomas R ^a   Kang, Chae H ^a   Krueger, Kathleen M ^a   Esbenshade, Timothy A ^a   Hancock, Arthur A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Electrical field stimulation; Guinea pig; Histamine H3 receptor; Ileum; Radiolig and binding; Receptor heterogeneity

Indexed keywords

3 (1H IMIDAZOL 4 YL)PROPYL BIS(4 FLUOROPHENYL)METHYL ETHER; 5 CYCLOHEXYL 1 [4 (4 IMIDAZOLYL) 1 PIPERIDYL] 1 PENTANONE; ALPHA METHYLHISTAMINE; BRIMONIDINE; BURIMAMIDE; CIPROXIFAN; CLOBENPROPIT; DIMAPRIT; FUB 322; HISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; IMETIT; IMMEPIP; IODOPHENPROPIT; N METHYLHISTAMINE; RADIOLIGAND; THIOPERAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG POTENCY; DRUG RECEPTOR BINDING; ELECTROSTIMULATION; GENE SEQUENCE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR GENE; SPECIES DIFFERENCE;

ANIMALS; CEREBRAL CORTEX; DOGS; ELECTRIC STIMULATION; GUINEA PIGS; HUMANS; ILEUM; METHYLHISTAMINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, HISTAMINE H3; SPECIES SPECIFICITY;

EID: 0035930838     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01518-7     Document Type: Article

References (44)

1. 3 receptor in rat cerebral cortex
2. 3) of histamine receptor
3. 3-receptors
4. 3 receptor binding sites in rat brain membranes: Modulations by guanine nucleotides and divalent cations
5. 3-receptors in guinea pig
6. 3 receptor
7. 3 receptor subtypes
8. 3 receptors inhibit cholinergic neurotransmission
9. 3 receptor isoforms with different brain expression and signaling properties
10. 3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex
11. Characterization of histaminergic receptors
12. 3-receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus
13. 3 receptors in guinea-pig cerebral cortex membranes
14. 3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia
15. 3) of histamine receptors on perivascular nerve terminals
16. 3-receptors in the inhibition of cholinergic contractile responses of the guinea pig ileum
17. 3 receptor heterogeneity?
18. 3 receptor agonists and antagonists
19. Histamine H-3 receptors: A new frontier in myocardial ischemia
20. 3 receptors: Role of two amino acids in the third transmembrane domain
21. 3 receptor mRNA at the third cytoplasmic loop is not detectable in humans
22. 3 receptor
23. 3 receptor reveals distinct species pharmacological profiles
24. 3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig
25. 3 receptor
26. 3 receptor desensitzation in the guinea-pig ileum
27. 3 receptors and other prejunctional receptor systems in the isolated guinea pig duodenum
28. 3 receptor agonist prodrug
29. 2, a new scale for the measurement of drug antagonism
30. 3-receptor mediated inhibition of serotonin release in the rat brain cortex
31. 3 receptor models
32. 3 receptor heterogeneity
33. 3 receptor: Evidence for two isoforms
34. 3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum
35. 3 receptor antagonists, in two functional models
36. 2D-adrenergic receptor regulated G protein activation in PC12 cell membranes
37. 3 ligands: Just pharmacological tools or potential therapeutic agents?
38. 3 subtype
39. 3-histamine receptor subtypes
40. 3 histamine receptor
41. α-methylhistamine binding differ from that of rodents
42. Receptor reserve and affinity of mu opioid agonists in mouse antinociception: Correlation with receptor binding
43. AGANTG: A Microsoft EXCEL 5.0-visual basic routine for the analysis of dose-reponse data